A DNA resequencing array for genes involved in Parkinson's disease

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Parkinson's disease (PD) presents complex etiology with both familial and sporadic forms.
• Familial PD is linked to rare, high-penetrance mutations, while sporadic PD may involve multiple low-penetrance variants.
• Current understanding suggests common variants explain limited familial clustering in sporadic PD, indicating a role for combined rare/common variants in implicated genes.

Purpose of the Study:

• To develop and validate a high-throughput sequencing array for investigating genes associated with Parkinson's disease pathogenesis.
• To identify common and rare genetic variants contributing to the genetic basis of PD.
• To assess the utility of this novel array technology for PD genetic research and clinical investigation.

Main Methods:

• Development of a CustomSeq Affymetrix resequencing array for high-throughput sequencing of 13 PD-associated genes (44 kb).
• Sequencing of 269 individuals (186 PD patients, 75 controls) using the array.
• Validation of array accuracy (>99.9%) through parallel capillary sequencing of five samples.

Main Results:

• Achieved high call rates (96.5% and 93.6%) across array versions.
• Identified modest associations between common variants in SNCA and LRRK2 genes and PD risk.
• Observed a trend suggesting an overrepresentation of rare variants in PD cases compared to controls across several genes.

Conclusions:

• The CustomSeq array provides a robust, cost-effective alternative to traditional targeted sequencing for PD research.
• This technology has potential for routine clinical investigation of PD genetic etiology.
• Further research using this approach can elucidate the complex genetic architecture of Parkinson's disease.